ARS Pharmaceuticals (SPRY) Competitors

Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) and ARS Pharmaceuticals (NASDAQ:SPRY) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, media sentiment, risk, institutional ownership, community ranking, earnings, profitability, valuation and analyst recommendations.

Does the media favor TLX or SPRY?

In the previous week, Telix Pharmaceuticals Limited American Depositary Shares had 6 more articles in the media than ARS Pharmaceuticals. MarketBeat recorded 13 mentions for Telix Pharmaceuticals Limited American Depositary Shares and 7 mentions for ARS Pharmaceuticals. ARS Pharmaceuticals' average media sentiment score of 1.47 beat Telix Pharmaceuticals Limited American Depositary Shares' score of 0.86 indicating that ARS Pharmaceuticals is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Telix Pharmaceuticals Limited American Depositary Shares	3 Very Positive mention(s)	3 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
ARS Pharmaceuticals	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Is TLX or SPRY more profitable?

Telix Pharmaceuticals Limited American Depositary Shares' return on equity of 0.00% beat ARS Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Telix Pharmaceuticals Limited American Depositary Shares	N/A	N/A	N/A
ARS Pharmaceuticals	N/A	-22.56%	-21.82%

Does the MarketBeat Community prefer TLX or SPRY?

ARS Pharmaceuticals received 20 more outperform votes than Telix Pharmaceuticals Limited American Depositary Shares when rated by MarketBeat users. However, 100.00% of users gave Telix Pharmaceuticals Limited American Depositary Shares an outperform vote while only 83.33% of users gave ARS Pharmaceuticals an outperform vote.

Company	Underperform	Outperform
Telix Pharmaceuticals Limited American Depositary Shares	Outperform Votes 5 100.00%	Underperform Votes No Votes
ARS Pharmaceuticals	Outperform Votes 25 83.33%	Underperform Votes 5 16.67%

Do analysts prefer TLX or SPRY?

Telix Pharmaceuticals Limited American Depositary Shares presently has a consensus price target of $22.00, indicating a potential upside of 27.39%. ARS Pharmaceuticals has a consensus price target of $31.00, indicating a potential upside of 111.03%. Given ARS Pharmaceuticals' stronger consensus rating and higher probable upside, analysts plainly believe ARS Pharmaceuticals is more favorable than Telix Pharmaceuticals Limited American Depositary Shares.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Telix Pharmaceuticals Limited American Depositary Shares	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
ARS Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	3.17

Do institutionals and insiders hold more shares of TLX or SPRY?

68.2% of ARS Pharmaceuticals shares are owned by institutional investors. 33.5% of ARS Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Which has higher valuation and earnings, TLX or SPRY?

Telix Pharmaceuticals Limited American Depositary Shares has higher revenue and earnings than ARS Pharmaceuticals.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Telix Pharmaceuticals Limited American Depositary Shares	$783.21M	7.46	N/A	N/A	N/A
ARS Pharmaceuticals	$97.12M	14.86	-$54.37M	-$0.16	-91.81

Summary

ARS Pharmaceuticals beats Telix Pharmaceuticals Limited American Depositary Shares on 9 of the 14 factors compared between the two stocks.